Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus Infection
丝状病毒感染背景下病毒翻译与先天免疫之间的交叉
基本信息
- 批准号:10425317
- 负责人:
- 金额:$ 61.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-13 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:3&apos Untranslated Regions5&apos Untranslated RegionsAddressAdenosineAfricaAngolaAntiviral ResponseBiological AssayBiological ModelsBiologyCase Fatality RatesCell Culture TechniquesCellsCessation of lifeCodeContainmentDataDetectionDiseaseDisease OutbreaksDouble-Stranded RNAEIF-2alphaEbola virusElementsEnzymesFamilyFatality rateFiloviridae InfectionsFilovirusGene ExpressionGenesGenetic TranslationGenomeGrowthGuanosineHealthHomeostasisHot SpotHourHumanImmuneImmune EvasionImmune responseImmune signalingIn VitroInfectionInnate Immune ResponseInosineInterferonsKnock-outKnockout MiceKnowledgeLaboratoriesLife Cycle StagesMarburgvirusMessenger RNAMicroRNAsModelingMolecular BiologyMusMutationNatural ImmunityNucleoproteinsOpen Reading FramesPathogenesisPattern recognition receptorPeptide Initiation FactorsPeriodicityPhosphorylationPhosphotransferasesProtein IsoformsProteinsPublic HealthRNARNA VirusesRecombinantsRegulationRegulatory ElementReportingResearchRoleSiteTestingTransfectionTranslatingTranslation InitiationTranslationsUntranslated RegionsViralViral GenesViral GenomeViral PhysiologyVirusVirus ReplicationWild Type MouseWorkZoonosesadenosine deaminasebaseemerging pathogenexperimental studyfollow-upin vivoinsightinterestmutantpathogenpathogenic virusresponsereverse geneticssensorviral fitness
项目摘要
The filoviruses Marburg virus (MARV) and Ebola virus (EBOV) are negative-sense RNA viral pathogens that cause periodic outbreaks of severe disease in humans. Despite their importance as emerging pathogens and as public health threats, many aspects of filovirus biology remain understudied. One major knowledge gap concerns the function(s) of the non-protein coding sequences present in filovirus genomes that correspond to 5’ and 3’ untranslated regions (UTRs) in viral mRNAs. These sequences comprise ~22% of the MARV genome and a similar amount of the EBOV genome and yet have been barely studied. Another knowledge gap concerns mechanisms by which viral mRNAs are translated to protein and how this may be sustained when innate immune responses are activated. Beginning to address this, we previously demonstrated a role for an upstream open reading frame (uORF), present in the 5’UTR of the EBOV L open reading frame (ORF), in the regulation of L translation. We further implicated this uORF as providing a means to sustain L expression under conditions innate antiviral defenses are activated. These data support a role for the UTRs as translational regulators which can modulate viral gene expression in the face of innate antiviral defenses. Our recent profiling of MARV 3’UTR function suggests negative-regulatory elements are present in the nucleoprotein (NP) mRNA and that positive regulatory elements are present in the L mRNA. In addition, we previously reported that the MARV genome appears to be edited by adenosine deaminase activity, particularly in sequences corresponding to the nucleoprotein (NP) mRNA 3’UTR. We now show that such mutations substantially increase mRNA translation efficiency, suggesting a means to maintain NP expression when the IFN-induced p150 form of adenosine deaminase acting on RNA 1 (ADAR1) is upregulated. Interestingly, the regulatory elements within the wildtype NP 3’UTR are also capable of triggering innate immune responses, but this immune stimulating activity is alleviated by the presumptive ADAR1 editing mutations. To follow up on these observations, we propose a combination of transfection- and live virus-based experiments to define the translation regulatory elements in MARV and EBOV 3’ UTRs and to determine how ADAR1 editing impacts viral gene expression and virus replication. We will fully evaluate the capacity of MARV and EBOV 5’ and 3’UTRs to trigger innate antiviral responses, defining the sensors responsible for this induction. Finally, we will create recombinant MARVs with wildtype and mutant 3’UTR sequences. These will be tested in wildtype and ADAR1-deficient cells and mice in order to determine how translational regulatory elements and ADAR1 editing impact viral growth and pathogenesis. Cumulatively, these studies will provide significant new insight into filovirus-host interactions related to translation and innate immune evasion.
丝状病毒马尔堡病毒 (MARV) 和埃博拉病毒 (EBOV) 是负义 RNA 病毒病原体,会导致人类周期性爆发严重疾病,尽管它们作为新兴病原体和公共卫生威胁具有重要意义,但丝状病毒生物学的许多方面仍未得到充分研究。一个主要的知识空白涉及丝状病毒基因组中存在的非蛋白质编码序列的功能,这些序列对应于病毒 mRNA 中的 5' 和 3' 非翻译区 (UTR)。序列包含约 22% 的 MARV 基因组和相似数量的 EBOV 基因组,但几乎没有研究过病毒 mRNA 翻译成蛋白质的机制以及当先天免疫反应被激活时如何维持这种机制。为了解决这个问题,我们之前证明了存在于 EBOV L 开放阅读框 (ORF) 5'UTR 中的上游开放阅读框 (uORF) 在 L 翻译调节中的作用。提供了一种在先天抗病毒防御激活的情况下维持 L 表达的方法。这些数据支持 UTR 作为翻译调节因子的作用,可以在先天抗病毒防御的情况下调节病毒基因表达。我们最近对 MARV 3'UTR 功能的分析表明。负调控元件存在于核蛋白 (NP) mRNA 中,正调控元件存在于 L mRNA 中。此外,我们之前报道过 MARV 基因组似乎是由腺苷编辑的。脱氨酶活性,特别是在核蛋白 (NP) mRNA 3'UTR 的相应序列中,我们现在表明,此类突变显着提高了 mRNA 翻译效率,表明当 IFN 诱导的 p150 形式的腺苷脱氨酶作用于 RNA 时,有一种维持 NP 表达的方法。 1 (ADAR1) 上调,野生型 NP 3'UTR 内的调节元件也能够触发先天免疫反应,但这种免疫刺激活性会被 NP 3'UTR 减弱。为了跟进这些观察结果,我们建议结合基于转染和活病毒的实验来定义 MARV 和 EBOV 3' UTR 中的翻译调控元件,并确定 ADAR1 编辑如何影响病毒基因表达和病毒。我们将全面评估 MARV 和 EBOV 5' 和 3'UTR 触发先天抗病毒反应的能力,定义负责这种诱导的传感器最后,我们将创建重组体。具有野生型和突变型 3'UTR 序列的 MARV 将在野生型和 ADAR1 缺陷细胞和小鼠中进行测试,以确定翻译调控元件和 ADAR1 编辑如何影响病毒生长和发病机制。与翻译和先天免疫逃避相关的丝状病毒-宿主相互作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher F Basler其他文献
Christopher F Basler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher F Basler', 18)}}的其他基金
Understanding how the MERS Coronavirus protein ORF4b interactions with importin alpha modulate innate immunity
了解 MERS 冠状病毒蛋白 ORF4b 与 importin alpha 的相互作用如何调节先天免疫
- 批准号:
10289173 - 财政年份:2021
- 资助金额:
$ 61.95万 - 项目类别:
VPS34 inhibitors as SARS-CoV-2 antivirals
VPS34 抑制剂作为 SARS-CoV-2 抗病毒药物
- 批准号:
10534720 - 财政年份:2021
- 资助金额:
$ 61.95万 - 项目类别:
Understanding how the MERS Coronavirus protein ORF4b interactions with importin alpha modulate innate immunity
了解 MERS 冠状病毒蛋白 ORF4b 与 importin alpha 的相互作用如何调节先天免疫
- 批准号:
10438878 - 财政年份:2021
- 资助金额:
$ 61.95万 - 项目类别:
Small Molecule Inhibitors of Ebola Virus Polymerase Function
埃博拉病毒聚合酶功能的小分子抑制剂
- 批准号:
10534719 - 财政年份:2021
- 资助金额:
$ 61.95万 - 项目类别:
Understanding how the MERS Coronavirus protein ORF4b interactions with importin alpha modulate innate immunity
了解 MERS 冠状病毒蛋白 ORF4b 与 importin alpha 的相互作用如何调节先天免疫
- 批准号:
10536332 - 财政年份:2021
- 资助金额:
$ 61.95万 - 项目类别:
VPS34 inhibitors as SARS-CoV-2 antivirals
VPS34 抑制剂作为 SARS-CoV-2 抗病毒药物
- 批准号:
10238577 - 财政年份:2021
- 资助金额:
$ 61.95万 - 项目类别:
Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus Infection
丝状病毒感染背景下病毒翻译与先天免疫之间的交叉
- 批准号:
10593400 - 财政年份:2020
- 资助金额:
$ 61.95万 - 项目类别:
Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus Infection
丝状病毒感染背景下病毒翻译与先天免疫之间的交叉
- 批准号:
10214516 - 财政年份:2020
- 资助金额:
$ 61.95万 - 项目类别:
Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus Infection
丝状病毒感染背景下病毒翻译与先天免疫之间的交叉
- 批准号:
10665712 - 财政年份:2020
- 资助金额:
$ 61.95万 - 项目类别:
相似海外基金
Regulation of RNA sensing and viral restriction by RNA structures
RNA 结构对 RNA 传感和病毒限制的调节
- 批准号:
10667802 - 财政年份:2023
- 资助金额:
$ 61.95万 - 项目类别:
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
- 批准号:
10725416 - 财政年份:2023
- 资助金额:
$ 61.95万 - 项目类别:
Mechanisms of viral RNA maturation by co-opting cellular exonucleases
通过选择细胞核酸外切酶使病毒 RNA 成熟的机制
- 批准号:
10814079 - 财政年份:2023
- 资助金额:
$ 61.95万 - 项目类别: